Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma

Abstract To identify risk factors for infection in patients with diffuse large B cell lymphoma (DLBCL) undergoing rituximab, cyclophosphamide, vincristine, adriamycin and prednisolone (R-CHOP) treatment. All patients with DLBCL who received R-CHOP from 2004–2014 in a tertiary Australian hospital wer...

Full description

Saved in:
Bibliographic Details
Main Authors: Claire Dendle, Michael Gilbertson, Tim Spelman, Rhonda L. Stuart, Tony M. Korman, Karin Thursky, Stephen Opat, Zoe McQuilten
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
R
Q
Online Access:https://doaj.org/article/8a6a1943b81149ab8bde5882ee1cadd6
Tags: Add Tag
No Tags, Be the first to tag this record!